Publications of Francesco Ciompi
2022
Papers in international journals
- M. Aubreville, N. Stathonikos, C. Bertram, R. Klopfleisch, N. Ter Hoeve, F. Ciompi, F. Wilm, C. Marzahl, T. Donovan, A. Maier, J. Breen, N. Ravikumar, Y. Chung, J. Park, R. Nateghi, F. Pourakpour, R. Fick, S. Ben Hadj, M. Jahanifar, A. Shephard, J. Dexl, T. Wittenberg, S. Kondo, M. Lafarge, V. Koelzer, J. Liang, Y. Wang, X. Long, J. Liu, S. Razavi, A. Khademi, S. Yang, X. Wang, R. Erber, A. Klang, K. Lipnik, P. Bolfa, M. Dark, G. Wasinger, M. Veta and K. Breininger, "Mitosis domain generalization in histopathology images - The MIDOG challenge.", Medical Image Analysis, 2022;84:102699.
- C. Mercan, M. Balkenhol, R. Salgado, M. Sherman, P. Vielh, W. Vreuls, A. Polonia, H. Horlings, W. Weichert, J. Carter, P. Bult, M. Christgen, C. Denkert, K. van de Vijver, J. Bokhorst, J. van der Laak and F. Ciompi, "Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer.", NPJ breast cancer, 2022;8(1):120.
- S. Marchesin, F. Giachelle, N. Marini, M. Atzori, S. Boytcheva, G. Buttafuoco, F. Ciompi, G. Di Nunzio, F. Fraggetta, O. Irrera, H. Muller, T. Primov, S. Vatrano and G. Silvello, "Empowering digital pathology applications through explainable knowledge extraction tools.", Journal of pathology informatics, 2022;13:100139.
- E. Munari, G. Querzoli, M. Brunelli, M. Marconi, M. Sommaggio, M. Cocchi, G. Martignoni, G. Netto, A. Calio, L. Quatrini, F. Mariotti, C. Luchini, I. Girolami, A. Eccher, D. Segala, F. Ciompi, G. Zamboni, L. Moretta and G. Bogina, "Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection.", Frontiers in immunology, 2022;13:954910.
- N. Marini, S. Marchesin, S. Otalora, M. Wodzinski, A. Caputo, M. van Rijthoven, W. Aswolinskiy, J. Bokhorst, D. Podareanu, E. Petters, S. Boytcheva, G. Buttafuoco, S. Vatrano, F. Fraggetta, J. van der Laak, M. Agosti, F. Ciompi, G. Silvello, H. Muller and M. Atzori, "Unleashing the potential of digital pathology data by training computer-aided diagnosis models without human annotations.", NPJ digital medicine, 2022;5(1):102.
- M. Hermsen, F. Ciompi, A. Adefidipe, A. Denic, A. Dendooven, B. Smith, D. van Midden, J. Brasen, J. Kers, M. Stegall, P. Bándi, T. Nguyen, Z. Swiderska-Chadaj, B. Smeets, L. Hilbrands and J. van der Laak, "Convolutional neural networks for the evaluation of chronic and inflammatory lesions in kidney transplant biopsies", American Journal of Pathology, 2022;192(10):1418-1432.
- G. Litjens, F. Ciompi and J. van der Laak, "A Decade of GigaScience: The Challenges of Gigapixel Pathology Images.", GigaScience, 2022;11.
- S. Satturwar, I. Girolami, E. Munari, F. Ciompi, A. Eccher and L. Pantanowitz, "Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review.", Diagnostic cytopathology, 2022;50(6):313-323.
- E. Chelebian, F. Ciompi and C. Wählby, "Seeded iterative clustering for histology region identification", 5, 2022.
Papers in conference proceedings
- L. Studer, J. Bokhorst, F. Ciompi, A. Fischer and H. Dawson, "Building-T-cell score is a potential predictor for more aggressive treatment in pT1 colorectal cancers", Proceedings of the ECDP 2022 18th European Congress on Digital Pathology, 2022.
Abstracts
- L. van Eekelen, E. Munari, L. Meesters, G. de Souza, M. Demirel-Andishmand, D. Zegers, M. Looijen-Salamon, S. Vos and F. Ciompi, "Nuclei detection with YOLOv5 in PD-L1 stained non-small cell lung cancer whole slide images", European Congress of Pathology, 2022.
- L. van Eekelen, E. Munari, I. Girolami, A. Eccher, J. van der Laak, K. Grunberg, M. Looijen-Salamon, S. Vos and F. Ciompi, "Inter-rater agreement of pathologists on determining PD-L1 status in non-small cell lung cancer", European Congress of Pathology, 2022.
- E. van Genugten, B. Piet, G. Schreibelt, T. van Oorschot, G. van den Heuvel, F. Ciompi, C. Jacobs, J. de Vries, M. van den Heuvel and E. Aarntzen, "Imaging tumor-infiltrating CD8 (+) T-cells in non-small cell lung cancer patients upon neo-adjuvant treatment with durvalumab", European Molecular Imaging Meeting, 2022.
- J. Spronck, L. Eekelen, L. Tessier, J. Bogaerts, L. van der Woude, M. van den Heuvel, W. Theelen and F. Ciompi, "Deep learning-based quantification of immune infiltrate for predicting response to pembrolizumab from pre-treatment biopsies of metastatic non-small cell lung cancer: A study on the PEMBRO-RT phase II trial", Immuno-Oncology and Technology, 2022.